Inventor · disambiguated record
Zhaoyang Meng
Also filed as: MENG ZHAOYANG
15 granted patents·2 pending applications·17 citations·filing 2006–2019
86Inventor score
Top patents by PatentIndex Score
17 records- 0184US10933056B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME·Filed 2019·Granted Mar 2, 2021·2 cites·11 claims
- 0278US11149036B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorACTON III JOHN J·Filed 2018·Granted Oct 19, 2021·3 cites·18 claims
- 0376US9663506B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 30, 2017·2 cites·16 claims
- 0476US9636337B2Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2016·Granted May 2, 2017·2 cites·30 claims
- 0575US8591943B2Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitorsDENG YONGQI·Filed 2010·Granted Nov 26, 2013·6 cites·2 claims
- 0667US8927562B2Fused tricyclic inhibitors of mammalian target of rapamycinMENG ZHAOYANG·Filed 2011·Granted Jan 6, 2015·1 cites·8 claims
- 0759US8609675B2Fused Tricyclic Compounds as novel mTOR inhibitorsCHENG CLIFF C·Filed 2010·Granted Dec 17, 2013·1 cites·14 claims
- 0849US11970479B23-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptorMERCK SHARP & DOHME LLC·Filed 2019·Granted Apr 30, 2024·0 cites·18 claims
- 0943US8901142B2Fused tricyclic compounds as mTOR inhibitorsMENG ZHAOYANG·Filed 2012·Granted Dec 2, 2014·0 cites·13 claims
- 1042US11655216B2Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted May 23, 2023·0 cites·8 claims
- 1140US10961215B2N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Mar 30, 2021·0 cites·19 claims
- 1239US10894775B2Piperidine derivatives as liver X receptor beta agonists, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jan 19, 2021·0 cites·12 claims
- 1338US10752587B2Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their useMERCK SHARP & DOHME·Filed 2016·Granted Aug 25, 2020·0 cites·10 claims
- 1438US2018305332A1Bispiperidinyl Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their UseMERCK SHARP & DOHME·Filed 2016·Application pending·0 cites
- 1536US8703784B2Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycinMENG ZHAOYANG·Filed 2011·Granted Apr 22, 2014·0 cites·10 claims
- 1633US2009131498A1Enantioselective Synthesis of Merrilactone and Its AnalogsDANISHEFSKY SAMUEL J·Filed 2006·Application pending·0 cites
- 1731US9227971B2Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitorsSIDDIQUI M ARSHAD·Filed 2011·Granted Jan 5, 2016·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Zhaoyang Meng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →